Connect your AI

Xenon Pharmaceuticals XENE Earnings yield

Earnings yield at other companies

Eli LillyLLY

3.1%+1.6pp

Johnson & JohnsonJNJ

3.6%-1.9pp

Jazz PharmaceuticalsJAZZ

-4.6%-11.2pp

Axsome TherapeuticsAXSM

-2.2%-0.8pp

Praxis Precision Medicines, Inc.PRAX

-3.6%-1.7pp

Neurocrine BiosciencesNBIX

5.1%+2.3pp

Other financials

Income statement

Revenue--100%

Operating income-$112.3M-54.4%

Net income-$102.3M-57.3%

EPS (diluted)-$1.17-41.0%

Balance sheet

Cash & equivalents$545.9M+368%

Total debt$7.5M-13.6%

Total equity$1.3B+90.0%

Total assets$1.4B+86.6%

Cash flow

Operating cash flow-$88.9M-44.2%

CapEx$133.0K+209%

Free cash flow-$89.0M-44.3%

Valuation

Market cap$5.11B+116%

Enterprise value$4.58B+104%

Profitability

Operating margin-4,974.3%—

Net margin-4,612.1%—

FCF margin-3,732.2%—

Returns & leverage

Return on equity-37.5%+8.7pp

Debt / equity0×0.0×

Current ratio27.8×+10.1×

Where this comes from

Calculated from Xenon Pharmaceuticals’s reported figures.

net income/market cap=-6.9%

Based on trailing twelve months.

The official record: Xenon Pharmaceuticals’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Xenon Pharmaceuticals's earnings yield.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Harbor at dusk

Questions, answered.

What is Xenon Pharmaceuticals's earnings yield?: Xenon Pharmaceuticals (XENE) reported earnings yield of -6.9% in Q1 2026.
How has Xenon Pharmaceuticals's earnings yield changed year-over-year?: Xenon Pharmaceuticals's earnings yield increased by 29.5% year-over-year, from -9.8% to -6.9%.
What is the long-term trend for Xenon Pharmaceuticals's earnings yield?: Over 5 years (2020 to 2025), Xenon Pharmaceuticals's earnings yield has grown at a 22.4% compound annual growth rate (CAGR), from -3.6% to -10%.
What does earnings yield mean?: Trailing-twelve-month net income divided by market capitalization at the quarter end — the inverse of the P/E ratio, expressed as a percentage.